Central and peripheral endogenous morphine

Anales de la Real Academia Nacional de Farmacia

Volumn 75, Issue 3, 2009, Pages 389-418

  Goumon, Yannick ^a   Laux, Alexis ^b   Muller, Arnaud ^b   Aunis, Dominique ^b  

^a INSERM   (France)

^b NONE

Author keywords

opioid receptor; Alkaloid; Analgesia; Morphine; Morphine 6 glucuronide

Indexed keywords

CALCIUM CHANNEL; DOPAMINE; ENDORPHIN; MORPHINE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; NICOTINE; POTASSIUM CHANNEL;

ADDICTION; ANALGESIA; ANTINOCICEPTION; BRAIN LEVEL; CELL SECRETION; CELLULAR DISTRIBUTION; CHANNEL GATING; DOPAMINE METABOLISM; HUMAN; MEMORY; NERVOUS SYSTEM DEVELOPMENT; NEUROBLASTOMA CELL; NEUROCHEMISTRY; NEUROMODULATION; NOCICEPTION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 72149106146     PISSN: None     EISSN: 1697428X     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Stefano, G. B., Goumon, Y., Casares, F., Cadet, P., Fricchione, G. L., Rialas, C., et al. (2000) Endogenous morphine. Trends Neurosci. 23(9): 436-442.
2. Lotsch, J. (2005) Pharmacokinetic-pharmacodynamic modeling of opioids. J. Pain Symptom. Manage. 29(5 Suppl): S90-103.
3. Lotsch, J. & Geisslinger, G. (2001) Morphine-6-glucuronide: an analgesic of the future? Clin. Pharmacokinet. 40(7): 485-499.
4. Pert, C. B., Pasternak, G. & Snyder, S. H. (1973) Opiate agonists and antagonists discriminated by receptor binding in brain. Science. 182(119): 1359-1361.
5. Trescot, A. M., Datta, S., Lee, M. & Hansen, H. (2008) Opioid pharmacology. Pain Physician. 11(2 Suppl): S133-153.
6. Zadina, J. E., Hackler, L., Ge, L. J. & Kastin, A. J. (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature. 386(6624): 499-502. (Pubitemid 27164076)
7. Zhang, Y., Chen, Q. & Yu, L. C. (2008) Morphine: a protective or destructive role in neurons? Neuroscientist. 14(6): 561-570.
8. Ding, Y. Q., Kaneko, T., Nomura, S. & Mizuno, N. (1996) Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat. J. Comp. Neurol. 367(3): 375-402.
9. Mansour, A., Fox, C. A., Burke, S., Akil, H. & Watson, S. J. (1995) Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS. J. Chem. Neuroanat. 8(4): 283-305.
10. Bianchi, C., Sellke, F. W., Del Vecchio, R. L., Tonks, N. K. & Neel, B. G. (1999) Receptor-type protein-tyrosine phosphatase mu is expressed in specific vascular endothelial beds in vivo. Exp. Cell Res. 248(1): 329-338.
11. Vidal, E. L., Patel, N. A., Wu, G., Fiala, M. & Chang, S. L. (1998) Interleukin-1 induces the expression of mu opioid receptors in endothelial cells. Immunopharmacology. 38(3): 261-266. (Pubitemid 28064596)
12. McCarthy, L., Wetzel, M., Sliker, J. K., Eisenstein, T. K. & Rogers, T. J. (2001) Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 62(2): 111-123. (Pubitemid 32195501)
13. Doyle, G. A., Sheng, X. R., Lin, S. S., Press, D. M., Grice, D. E., Buono, R. J., et al. (2007) Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. Gene. 395(1-2): 98-107.
14. Xu, J., Xu, M., Hurd, Y. L., Pasternak, G. W. & Pan, Y. X. (2009) Isolation and characterization of new exon 11-associated N-terminal splice variants of the human mu opioid receptor gene. J. Neurochem. 108(4): 962-972.
15. Pan, Y. X. (2005) Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol. 24(11): 736-750.
16. Nevo, I., Avidor-Reiss, T., Levy, R., Bayewitch, M. & Vogel, Z. (2000) Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes. Neuropharmacology. 39(3): 364-371.
17. Williams, J. T., Christie, M. J. & Manzoni, O. (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81(1): 299-343.
18. Cohen, G. A., Doze, V. A. & Madison, D. V. (1992) Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron. 9(2): 325-335.
19. Jiang, Z. G. & North, R. A. (1991) Membrane properties and synaptic responses of rat striatal neurones in vitro. J. Physiol. 443: 533-553.
20. Connor, M. & Henderson, G. (1996) delta- and mu-opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br. J. Pharmacol. 117(2): 333-340.
21. Tang, Y., Chen, K. X., Jiang, H. L., Wang, Z. X., Ji, R. Y. & Chi, Z. Q. (1996) Molecular modeling of mu opioid receptor and its interaction with ohmefentanyl. Zhongguo Yao Li Xue Bao. 17(2): 156-160. (Pubitemid 26101463)
22. Pasternak, G. W. (2007) When it comes to opiates, just say NO. J. Clin. Invest. 117(11): 3185-3187.
23. Stefano, G. B., Goumon, Y., Bilfinger, T. V., Welters, I. D. & Cadet, P. (2000) Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog. Neurobiol. 60(6): 513-530.
24. Chuang, L. F., Killam, K. F., Jr. & Chuang, R. Y. (1997) Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulfate. J. Biol. Chem. 272(43): 26815-26817.
25. Ikeda, K., Kobayashi, T., Kumanishi, T., Niki, H. & Yano, R. (2000) Involvement of G-protein-activated inwardly rectifying K (GIRK) channels in opioid-induced analgesia. Neurosci. Res. 38(1): 113-116.
26. Marker, C. L., Stoffel, M. & Wickman, K. (2004) Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia. J. Neurosci. 24(11): 2806-2812.
27. Vaughan, C. W., Bagley, E. E., Drew, G. M., Schuller, A., Pintar, J. E., Hack, S. P., et al. (2003) Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br. J. Pharmacol. 139(2): 362-367.
28. Marker, C. L., Lujan, R., Loh, H. H. & Wickman, K. (2005) Spinal G-protein-gated potassium channels contribute in a dose-dependent manner to the analgesic effect of mu- and delta- but not kappa-opioids. J. Neurosci. 25(14): 3551-3559. (Pubitemid 40503681)
29. Nakatsuka, T., Fujita, T., Inoue, K. & Kumamoto, E. (2008) Activation of GIRK channels in substantia gelatinosa neurones of the adult rat spinal cord: a possible involvement of somatostatin. J. Physiol. 586(10): 2511-2522.
30. Cruz, H. G., Berton, F., Sollini, M., Blanchet, C., Pravetoni, M., Wickman, K., et al. (2008) Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice. J. Neurosci. 28(15): 4069-4077.
31. Torrecilla, M., Quillinan, N., Williams, J. T. & Wickman, K. (2008) Pre- and postsynaptic regulation of locus coeruleus neurons after chronic morphine treatment: a study of GIRK-knockout mice. Eur. J. Neurosci. 28(3): 618-624.
32. Coller, J. K., Christrup, L. L. & Somogyi, A. A. (2008) Role of active metabolites in the use of opioids. Eur. J. Clin. Pharmacol.
33. Ohno, S. & Nakajin, S. (2009) Determination of mRNA expression of human UDP-glucuronosyltransferases and application for localization in various human tissues by real-time reverse transcriptase-polymerase chain reaction. Drug Metab. Dispos. 37(1): 32-40.
34. Radominska-Pandya, A., Little, J. M. & Czernik, P. J. (2001) Human UDP-glucuronosyltransferase 2B7. Cutr. Drug Metab. 2(3): 283-298.
35. Yamada, H., Ishii, K., Ishii, Y., Ieiri, I., Nishio, S., Morioka, T., et al. (2003) Formation of highly analgesic morphine-6-glucuronide following physiologic concentration of morphine in human brain. J. Toxicol. Sci. 28(5): 395-401.
36. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., et al. (1997) The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 7(4): 255-269. (Pubitemid 27358064)
37. Mackenzie, P. I., Walter Bock, K., Burchell, B., Guillemette, C., Ikushiro, S., Iyanagi, T., et al. (2005) Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet. Genomics. 15(10): 677-685.
38. Ohno, S., Kawana, K. & Nakajin, S. (2008) Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties. Drug Metab. Dispos. 36(4): 688-694.
39. King, C. D., Rios, G. R., Assouline, J. A. & Tephly, T. R. (1999) Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate. Arch. Biochem. Biophys. 365(1): 156-162.
40. Suleman, F. G., Abid, A., Gradinaru, D., Daval, J. L., Magdalou, J. & Minn, A. (1998) Identification of the uridine diphosphate glucuronosyltransferase isoform UGT1A6 in rat brain and in primary cultures of neurons and astrocytes. Arch. Biochem. Biophys. 358(1): 63-67.
41. Brands, A., Munzel, P. A. & Bock, K. W. (2000) In situ hybridization studies of UDP-glucuronosyltransferase UGT1A6 expression in rat testis and brain. Biochem. Pharmacol. 59(11): 1441-1444.
42. Lotsch, J. (2005) Opioid metabolites. J. Pain Symptom. Manage. 29(5 Suppl): S10-24.
43. Yeh, S. Y., Gorodetzky, C. W. & Krebs, H. A. (1977) Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans. J. Pharm. Sci. 66(9): 1288-1293.
44. Zheng, M., McErlane, K. M. & Ong, M. C. (1998) High-performance liquid chromatography-mass spectrometry-mass spectrometry analysis of morphine and morphine metabolites and its application to a pharmacokinetic study in male Sprague-Dawley rats. J. Pharm. Biomed. Anal. 16(6): 971-980.
45. Wu, D., Kang, Y. S., Bickel, U. & Pardridge, W. M. (1997) Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab Dispos. 25(6): 768-771. (Pubitemid 27259979)
46. Grace, D. & Fee, J. P. (1996) A comparison of intrathecal morphine-6-glucuronide and intrathecal morphine sulfate as analgesics for total hip replacement. Anesth. Analg. 83(5): 1055-1059.
47. Dahan, A., van Dorp, E., Smith, T. & Yassen, A. (2008) Morphine-6-glucuronide (M6G) for postoperative pain relief. Eur. J. Pain. 12(4): 403-411.
48. van Dorp, E. L., Romberg, R., Sarton, E., Bovill, J. G. & Dahan, A. (2006). Morphine-6-Glucuronide: Morphine's Successor for Postoperative Pain Relief? Anesth. Analg. 102(6): 1789-1797.
49. Mavrojannis, M. (1903) Action Cataleptique de la Morphine chez les Rats. Contribution a la Theorie Toxique da la Catalepsie. Comptes rendues Soc. Biol. 55: 1092-1094.
50. Gintzler, A. R., Mohacsi, E. & Spector, S. (1976) Radioimmunoassay for the simultaneous determination of morphine and codeine. Eur. J. Pharmacol. 38(1): 149-156.
51. Shorr, J., Foley, K. & Spector, S. (1978) Presence of a non-peptide morphine-like compound in human cerebrospinal fluid. Life Sci. 23(20): 2057-2062. (Pubitemid 9083541)
52. Oka, K., Kantrowitz, J. D. & Spector, S. (1985) Isolation of morphine from toad skin. Proc. Natl. Acad. Sci. USA. 82(6): 1852-1854.
53. Spector, S., Kantrowitz, J. D. & Oka, K. (1985) Presence of endogenous morphine in toad skin. Prog. Clin. Biol. Res. 192: 329-332.
54. Goldstein, A., Barrett, R. W., James, I. F., Lowney, L. I., Weitz, C. J., Knipmeyer, L. L., et al. (1985) Morphine and other opiates from beef brain and adrenal. Proc. Natl. Acad. Sci. USA. 82(15): 5203-5207.
55. Stefano, G. B., Digenis, A., Spector, S., Leung, M. K., Bilfinger, T. V., Makman, M. H., et al. (1993) Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc. Natl. Acad. Sci. USA. 90(23): 11099-11103.
56. Leung, M. K., Dissous, C., Capron, A., Woldegaber, H., Duvaux-Miret, O., Pryor, S., et al. (1995) Schistosoma mansoni: the presence and potential use of opiate-like substances. Exp. Parasitol. 81(2): 208-215.
57. Goumon, Y., Casares, F., Pryor, S., Ferguson, L., Brownawell, B., Cadet, P., et al. (2000) Ascaris suum, an intestinal parasite, produces morphine. J. Immunol. 165(1): 339-343. (Pubitemid 30429525)
58. Hazum, E., Sabatka, J. J., Chang, K. J., Brent, D. A., Findlay, J. W. & Cuatrecasas, P. (1981) Morphine in cow and human milk: could dietary morphine constitute a ligand for specific morphine (mu) receptors? Science. 213(4511): 1010-1012.
59. Weitz, C. J., Lowney, L. I., Faull, K. F., Feistner, G. & Goldstein, A. (1986) Morphine and codeine from mammalian brain. Proc. Natl. Acad. Sci. USA. 83(24): 9784-9788.
60. Donnerer, J., Oka, K., Brossi, A., Rice, K. C. & Spector, S. (1986) Presence and formation of codeine and morphine in the rat. Proc. Natl. Acad. Sci. USA. 83(12): 4566-4567.
61. Weitz, C. J., Faull, K. F. & Goldstein, A. (1987) Synthesis of the skeleton of the morphine molecule by mammalian liver. Nature. 330(6149): 674-677.
62. Matsubara, K., Fukushima, S., Akane, A., Kobayashi, S. & Shiono, H. (1992) Increased urinary morphine, codeine and tetrahydropapaveroline in parkinsonian patient undergoing L-3,4-dihydroxyphenylalanine therapy: a possible biosynthetic pathway of morphine from L-3,4-dihydroxyphenylalanine in humans. J. Pharmacol. Exp. Ther. 260(3): 974-978.
63. Neri, C., Ghelardini, C., Sotak, B., Palmiter, R. D., Guarna, M., Stefano, G., et al. (2008) Dopamine is necessary to endogenous morphine formation in mammalian brain in vivo. J. Neurochem. 106(6): 2337-2344.
64. Boettcher, C., Fellermeier, M., Boettcher, C., Drager, B. & Zenk, M. H. (2005). How human neuroblastoma cells make morphine. Proc. Natl. Acad. Sci. USA. 102(24): 8495-8500.
65. Poeaknapo, C. (2005) Mammalian morphine: de novo formation of morphine in human cells. Med. Sci. Monit. 11(5): MS6-17.
66. Poeaknapo, C., Schmidt, J., Brandsch, M., Drager, B. & Zenk, M. H. (2004) Endogenous formation of morphine in human cells. Proc. Natl. Acad. Sci. USA. 101(39): 14091-14096.
67. Zhu, W., Mantione, K. J., Shen, L., Cadet, P., Esch, T., Goumon, Y., et al. (2005) Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: cyp2d6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med. Sci. Monit. 11(11): BR397-404.
68. Zhu, W., Cadet, P., Baggerman, G., Mantione, K. J. & Stefano, G. B. (2005) Human white blood cells synthesize morphine: CYP2D6 modulation. J. Immunol. 175(11): 7357-7362.
69. Baker, H., Abate, C., Szabo, A. & Joh, T. H. (1991) Species-specific distribution of aromatic L-amino acid decarboxylase in the rodent adrenal gland, cerebellum, and olfactory bulb. J. Comp. Neurol. 305(1): 119-129.
70. Ikemoto, K., Kitahama, K., Jouvet, A., Arai, R., Nishimura, A., Nishi, K., et al. (1997) Demonstration of L-dopa decarboxylating neurons specific to human striatum. Neurosci. Lett. 232(2): 111-114.
71. Ikemoto, K., Kitahama, K., Nishimura, A., Jouvet, A., Nishi, K., Arai, R., et al. (1999) Tyrosine hydroxylase and aromatic L-amino acid decarboxylase do not coexist in neurons in the human anterior cingulate cortex. Neurosci. Lett. 269(1): 37-40.
72. Kitahama, K., Geffard, M., Araneda, S., Arai, R., Ogawa, K., Nagatsu, I., et al. (2007) Localization of L-DOPA uptake and decarboxylating neuronal structures in the cat brain using dopamine immunohistochemistry. Brain Res. 1167: 56-70.
73. Ugrumov, M. V., Melnikova, V. I., Lavrentyeva, A. V., Kudrin, V. S. & Rayevsky, K. S. (2004) Dopamine synthesis by non-dopaminergic neurons expressing individual complementary enzymes of the dopamine synthetic pathway in the arcuate nucleus of fetal rats. Neuroscience. 124(3): 629-635.
74. Bianchi, E., Alessandrini, C., Guarna, M. & Tagliamonte, A. (1993) Endogenous codeine and morphine are stored in specific brain neurons. Brain Res. 627(2): 210-215. (Pubitemid 23313257)
75. Bianchi, E., Guarna, M. & Tagliamonte, A. (1994) Immunocytochemical localization of endogenous codeine and morphine. Adv. Neuroimmunol. 4(2): 83-92.
76. Meijerink, W. J., Molina, P. E. & Abumrad, N. N. (1999) Mammalian opiate alkaloid synthesis: lessons derived from plant biochemistry. Shock. 12(3): 165-173.
77. Goumon, Y., Bouret, S., Casares, F., Zhu, W., Beauvillain, J. C. & Stefano, G. B. (2000) Lipopolysaccharide increases endogenous morphine levels in rat brain. Neurosci. Lett. 293(2): 135-138.
78. Muller, A., Glattard, E., Taleb, O., Kemmel, V., Laux, A., Miehe, M., et al. (2008) Endogenous Morphine in SH-SY5Y Cells and the Mouse Cerebellum. PLoS One. 3(2): Epub www.plosone.org/doi/pone.0001641.
79. Cardinale, G. J., Donnerer, J., Finck, A. D., Kantrowitz, J. D., Oka, K. & Spector, S. (1987) Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sci. 40(3): 301-306.
80. Guarna, M., Neri, C., Petrioli, F. & Bianchi, E. (1998) Potassium-induced release of endogenous morphine from rat brain slices. J. Neurochem. 70(1): 147-152. (Pubitemid 28020838)
81. Agis-Torres, A., Ball, S. G. & Vaughan, P. F. (2002) Chronic treatment with nicotine or potassium attenuates depolarisation-evoked noradrenaline release from the human neuroblastoma SH-SY5Y. Neurosci. Lett. 331(3): 167-170.
82. van Dorp, E. L., Morariu, A. & Dahan, A. (2008) Morphine-6- glucuronide: potency and safety compared with morphine. Expert Opin. Pharmacother. 9(11): 1955-1961.
83. Mrkusich, E. M., Kivell, B. M., Miller, J. H. & Day, D. J. (2004) Abundant expression of mu and delta opioid receptor mRNA and protein in the cerebellum of the fetal, neonatal, and adult rat. Brain Res. Dev. Brain Res. 148(2): 213-222.
84. Zhang, Y., Pan, Y. X., Kolesnikov, Y. & Pasternak, G. W. (2006) Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variant mMOR-1B4 in the mouse central nervous system. Brain Res. 1099(1): 33-43.
85. Guarna, M., Bianchi, E., Bartolini, A., Ghelardini, C., Galeotti, N., Bracci, L., et al. (2002) Endogenous morphine modulates acute thermonociception in mice. J. Neurochem. 80(2): 271-277. (Pubitemid 34809372)
86. Kieffer, B. L. & Gaveriaux-Ruff, C. (2002) Exploring the opioid system by gene knockout. Prog. Neurobiol. 66(5): 285-306.
87. Galeotti, N., Stefano, G. B., Guarna, M., Bianchi, E. & Ghelardini, C. (2006) Signaling pathway of morphine induced acute thermal hyperalgesia in mice. Pain. 123(3): 294-305.
88. Rubovitch, V., Gafni, M. & Sarne, Y. (2003) The mu opioid agonist DAMGO stimulates cAMP production in SK-N-SH cells through a PLC-PKC-Ca++ pathway. Brain Res. Mol. Brain Res. 110(2): 261-266.
89. Crain, S. M. & Shen, K. F. (2001) Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res. 888(1): 75-82.
90. Guarna, M., Ghelardini, C., Galeotti, N., Bartolini, A., Noli, L., Neri, C., et al. (2004) Effects of endogenous morphine deprivation on memory retention of passive avoidance learning in mice. Int. J. Neuropsychopharmacol. 7(3): 311-319.
91. Miller, K. K. & Lupica, C. R. (1997) Neuropeptide FF inhibition of morphine effects in the rat hippocampus. Brain Res. 750(1-2): 81-86. (Pubitemid 27116251)
92. Moron, J. A., Abul-Husn, N. S., Rozenfeld, R., Dolios, G., Wang, R. & Devi, L. A. (2007) Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: a proteomics study focusing on endocytic proteins. Mol. Cell. Proteomics. 6(1): 29-42.
93. Niu, L., Cao, B., Zhu, H., Mei, B., Wang, M., Yang, Y., et al. (2008) Impaired in vivo synaptic plasticity in dentate gyrus and spatial memory in juvenile rats induced by prenatal morphine exposure. Hippocampus.
94. Sargeant, T. J., Day, D. J., Mrkusich, E. M., Foo, D. F. & Miller, J. H. (2007) Mu opioid receptors are expressed on radial glia but not migrating neuroblasts in the late embryonic mouse brain. Brain Res. 1175: 28-38.
95. Eisch, A. J., Barrot, M., Schad, C. A., Self, D. W. & Nestler, E. J. (2000) Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl. Acad. Sci. USA. 97(13): 7579-7584.
96. Mandyam, C. D., Norris, R. D. & Eisch, A. J. (2004) Chronic morphine induces premature mitosis of proliferating cells in the adult mouse subgranular zone. J. Neurosci. Res. 76(6), 783-794
97. Persson, A. I., Thorlin, T., Bull, C. & Eriksson, P. S. (2003) Opioid-induced proliferation through the MAPK pathway in cultures of adult hippocampal progenitors. Mol. Cell. Neurosci. 23(3): 360-372.
98. Persson, A. I., Thorlin, T., Bull, C., Zarnegar, P., Ekman, R., Terenius, L., et al. (2003) Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors. Eur. J. Neurosci. 17(6): 1159-1172.
99. Harburg, G. C., Hall, F. S., Harrist, A. V., Sora, I., Uhl, G. R. & Eisch, A. J. (2007) Knockout of the mu opioid receptor enhances the survival of adult-generated hippocampal granule cell neurons. Neuroscience. 144(1): 77-87. (Pubitemid 44839047)
100. Weber, M., Modemann, S., Schipper, P., Trauer, H., Franke, H., Illes, P., et al. (2006) Increased polysialic acid neural cell adhesion molecule expression in human hippocampus of heroin addicts. Neuroscience. 138(4): 1215-1223.
101. Brailoiu, E., Hoard, J., Brailoiu, G. C., Chi, M., Godbolde, R. & Dun, N. J. (2004) Ultra low concentrations of morphine increase neurite outgrowth in cultured rat spinal cord and cerebral cortical neurons. Neurosci. Lett. 365(1):10-13.
102. Tenconi, B., Lesma, E., DiGiulio, A. M. & Gorio, A. (1996) High opioid doses inhibit whereas low doses enhance neuritogenesis in PC12 cells. Brain Res. Dev. Brain Res. 94(2): 175-181.
103. Zeng, Y. S., Nie, J. H., Zhang, W., Chen, S. J. & Wu, W. (2007) Morphine acts via mu-opioid receptors to enhance spinal regeneration and synaptic reconstruction of primary afferent fibers injured by sciatic nerve crush. Brain Res. 1130(1): 108-113. (Pubitemid 46053881)
104. Horvath, R. J. & DeLeo, J. A. (2009) Morphine enhances microglial migration through modulation of P2X4 receptor signaling. J. Neurosci. 29(4): 998-1005.
105. Zhu, W., Mantione, K. J., Casares, F. M., Cadet, P., Kim, J. W., Bilfinger, T. V., et al. (2006) Alcohol-, nicotine-, and cocaine-evoked release of morphine from invertebrate ganglia: model system for screening drugs of abuse. Med. Sci. Monit. 12(5): BR155-161.
106. Stefano, G. B., Bianchi, E., Guarna, M., Fricchione, G. L., Zhu, W., Cadet, P., et al. (2007) Nicotine, alcohol and cocaine coupling to reward processes via endogenous morphine signaling: the dopamine-morphine hypothesis. Med. Sci. Monit. 13(6): RA91-102.
107. Aunis, D. (1998) Exocytosis in chromaffin cells of the adrenal medulla. Int. Rev. Cytol. 181: 213-320.
108. Aunis, D., Miras-Portugal, M. T. & Mandel, P. (1974) Bovine adrenal medullary dopamine-beta-hydroxylase: studies on the structure. Biochim. Biophys. Acta. 365: 259-273.
109. Aunis, D., Miras-Portugal, M. T. & Mandel, P. (1975) Bovine adrenal medullary dopamine-beta-hydroxylase: studies on interaction with concanavalin A. J. Neurochem. 24: 425-431.
110. Goumon, Y., Zhu, W., Weeks, B. S., Casares, F., Cadet, P., Bougaeva, M., et al. (2000) Identification of morphine in the adrenal medullary chromaffin PC-12 cell line. Brain Res. Mol. Brain Res. 81(1-2): 177-180.
111. Epple, A., Navarro, I., Horak, P. & Spector, S. (1993) Endogenous morphine and codeine: release by the chromaffin cells of the eel. Life Sci. 52(16): PL117-121.
112. Boettcher, C., Fischer, W. & Zenk, M. H. (2006) Comment on «Human White Blood Cells Synthesize Morphine: CYP2D6 Modulation». J. Immunol. 176(10): 5703-5704.
113. Brix-Christensen, V., Goumon, Y., Tonnesen, E., Chew, M., Bilfinger, T. & Stefano, G. B. (2000) Endogenous morphine is produced in response to cardiopulmonary bypass in neonatal pigs. Acta Anaesthesiol. Scand. 44(10): 1204-1208.
114. Brix-Christensen, V., Tonnesen, E., Sánchez, R. G., Bilfinger, T. V. & Stefano, G. B. (1997) Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response? Int. J. Cardiol. 62(3): 191-197. (Pubitemid 28060149)
115. Yoshida, S., Ohta, J., Yamasaki, K., Kamei, H., Harada, Y., Yahara, T., et al. (2000) Effect of surgical stress on endogenous morphine and cytokine levels in the plasma after laparoscopoic or open cholecystectomy. Surg. Endosc. 14(2): 137-140.
116. Pan, Y. X., Xu, J., Bolan, E., Moskowitz, H. S., Xu, M. & Pasternak, G. W. (2005) Identification of four novel exon 5 splice variants of the mouse mu-opioid receptor gene: functional consequences of C-terminal splicing. Mol. Pharmacol. 68(3): 866-875.
117. Sharp, B. M., Roy, S. & Bidlack, J. M. (1998) Evidence for opioid receptors on cells involved in host defense and the immune system. J. Neuroimmunol. 83(1-2): 45-56. (Pubitemid 28280950)
118. Dinda, A., Gitman, M. & Singhal, P. C. (2005) Immunomodulatory effect of morphine: therapeutic implications. Expert. Opin. Drug. Saf. 4(4): 669-675.
119. Mellon, R. D. & Bayer, B. M. (1998) Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J. Neuroimmunol. 83(1-2): 19-28.
120. Mellon, R. D. & Bayer, B. M. (1998) Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res. 789(1): 56-67.
121. Mellon, R. D. & Bayer, B. M. (1999) The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. J. Pharmacol. Exp. Ther. 288(2): 635-642.